We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations for use in various therapeutic areas, including anti-infective, antimalarial, anti-tuberculosis, cardiology, health and nutrition, oncology, ophthalmology, and pain management. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was incorporated in 1969 and is headquartered in Mumbai, India.
TODAY'S HIGH
768.95
TODAY'S LOW
705
52 WEEK HIGH
1197
52 WEEK LOW
662.25
% of Shares Held by
All Insider
76.87%
% of Shares Held by
Institutions
0.00%
% of Float Held by
Institutions
0.00%
Number of Institutions
Holding Shares
0
MARKET CAP
699 Cr.
ETERPRISE VALUE
752.28 Cr.
NO. OF SHARES
92 Lakhs
BOOK VALUE
312.347
DIV. YIELD
5%
DEBT
79.73 Cr.
GROSS PROFIT
246.47 Cr.
CASH
26.49 Cr.
REVENUE
394.61 Cr.
REVENUE/SHARE
428.938
Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|
Investments | 0 | 0 | 0 | 0 |
Change To Liabilities | 1.08 Cr. | 1.10 Cr. | -5.35 Cr. | 4.48 Cr. |
Total cashflows from Investing Activities | -15.58 Cr. | -15.65 Cr. | -5.46 Cr. | -3.72 Cr. |
Net Borrowings | -7.44 Cr. | -13.08 Cr. | 17.56 Cr. | 47.77 Lakhs |
Total Cash from Financing Activities | -17.54 Cr. | -25.64 Cr. | 6.72 Cr. | -9.93 Cr. |
Other Liabilities | -18.36 Cr. | -14.19 Cr. | -61.04 Lakhs | 11.81 Cr. |
Total Assets | 39.55 Lakhs | 1.55 Lakhs | 23.60 Lakhs | 23.60 Lakhs |
Net Income | 72.88 Cr. | 35.70 Cr. | 24.78 Cr. | -10.74 Cr. |
Change in Cash | 1.26 Cr. | 15.67 Cr. | 1.58 Cr. | -2.73 Cr. |
Effect of Exchange Rate | 0 | 0 | 0 | 0 |
Total Cash from Operating Activities | 34.39 Cr. | 56.97 Cr. | 32.82 Lakhs | 10.92 Cr. |
Depreciation | 9.47 Cr. | 8.54 Cr. | 8.27 Cr. | 7.99 Cr. |
Other Cashflows from Investing Activities | 3.71 Cr. | 2.34 Cr. | 30.38 Lakhs | 1.75 Cr. |
Dividends Paid | -3.95 Cr. | -1.60 Cr. | -1.60 Cr. | -1.60 Cr. |
Change to Inventory | -2.31 Cr. | -3.88 Cr. | -97.41 Lakhs | -4.05 Cr. |
Change to Account Receivables | -22.95 Cr. | 24.87 Cr. | -28.69 Cr. | -5.16 Cr. |
Other Cashflows from Financing Activities | -6.53 Cr. | -10.96 Cr. | -11.07 Cr. | -10.41 Cr. |
Change to Net Income | -5.41 Cr. | 4.82 Cr. | 2.90 Cr. | 6.59 Cr. |
Capital Expenditures | -20.62 Cr. | -18.03 Cr. | -5.80 Cr. | -5.63 Cr. |
Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|
Research Development | None | None | None | None |
Effect of Accounting Charges | None | None | None | None |
Income Before Tax | 95.26 Cr. | 41.33 Cr. | 26.87 Cr. | -12.59 Cr. |
Minority Interest | -7 k | -6 k | -5 k | -1.75 Lakhs |
Net Income | 86.15 Cr. | 40.94 Cr. | 27.38 Cr. | -5.71 Cr. |
Selling General Administrative | 51.97 Cr. | 44.36 Cr. | 49.06 Cr. | 54.07 Cr. |
Gross Profit | 246.47 Cr. | 150.53 Cr. | 137.04 Cr. | 114.32 Cr. |
Ebit | 86.15 Cr. | 40.94 Cr. | 27.38 Cr. | -5.71 Cr. |
Operating Income | 86.15 Cr. | 40.94 Cr. | 27.38 Cr. | -5.71 Cr. |
Other Operating Expenses | 98.86 Cr. | 56.67 Cr. | 52.32 Cr. | 57.97 Cr. |
Interest Expense | -8.77 Cr. | -10.96 Cr. | -11.07 Cr. | -10.40 Cr. |
Extraordinary Items | None | None | None | None |
Non Recurring | None | None | None | None |
Other Items | None | None | None | None |
Income Tax Expense | 22.38 Cr. | 5.62 Cr. | 2.09 Cr. | -1.83 Cr. |
Total Revenue | 394.61 Cr. | 230.66 Cr. | 201.58 Cr. | 183.75 Cr. |
Total Operating Expenses | 308.45 Cr. | 189.72 Cr. | 174.20 Cr. | 189.46 Cr. |
Cost of Revenue | 148.13 Cr. | 80.13 Cr. | 64.54 Cr. | 69.42 Cr. |
Total Other Income Expense Net | 9.10 Cr. | 38.43 Lakhs | -51.01 Lakhs | -6.88 Cr. |
Discontinued Operations | None | None | None | None |
Net Income from Continuous Ops. | 72.88 Cr. | 35.70 Cr. | 24.78 Cr. | -10.75 Cr. |
Net Income Applicable to Common Shares | 72.88 Cr. | 35.70 Cr. | 24.78 Cr. | -10.74 Cr. |
Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|
Intangible Assets | 98.88 Lakhs | 1.20 Cr. | 1.42 Cr. | 1.64 Cr. |
Capital Surplus | 0 | 35.06 Cr. | 35.04 Cr. | 34.81 Cr. |
Total Liabilities | 140.29 Cr. | 152.63 Cr. | 166.88 Cr. | 156.03 Cr. |
Stock Holder Equity | 287.48 Cr. | 218.50 Cr. | 183.02 Cr. | 158.09 Cr. |
Minority Interest | -7 k | -6 k | -5 k | -1.75 Lakhs |
Other Liabilities | 20.35 Cr. | 31.16 Cr. | 29.92 Cr. | 33.74 Cr. |
Total Assets | 427.78 Cr. | 371.14 Cr. | 349.91 Cr. | 314.10 Cr. |
Common Stock | 9.20 Cr. | 9.18 Cr. | 9.18 Cr. | 9.18 Cr. |
Retained Earnings | 0 | 139.06 Cr. | 102.99 Cr. | 77.81 Cr. |
Other Liabilities | 6.47 Cr. | 94.83 Lakhs | 0 | 0 |
Good Will | 0 | 0 | 0 | 0 |
Treasury Stock | 278.28 Cr. | 35.19 Cr. | 35.79 Cr. | 36.27 Cr. |
Other Assets | 8.93 Cr. | 4.86 Cr. | 9.79 Cr. | 11.49 Cr. |
Cash | 26.49 Cr. | 19.01 Cr. | 3.34 Cr. | 1.75 Cr. |
Current Liabilities | 109.51 Cr. | 128.30 Cr. | 154.81 Cr. | 146.68 Cr. |
Long Term Asset Charges | 0 | 0 | 4.57 Cr. | 6.63 Cr. |
Short Long Term Debt | 54.66 Cr. | 5.86 Cr. | 10.84 Cr. | 5.53 Cr. |
Other Stockholder Equity | 278.28 Cr. | 35.19 Cr. | 35.79 Cr. | 36.27 Cr. |
Property Plant Equipment | 145.57 Cr. | 134.36 Cr. | 122.42 Cr. | 124.21 Cr. |
Total Cur. Assets | 214.15 Cr. | 185.46 Cr. | 180.49 Cr. | 149.86 Cr. |
Long Term Investments | 58.13 Cr. | 45.23 Cr. | 35.77 Cr. | 26.89 Cr. |
Net Tangible Assets | 286.50 Cr. | 217.29 Cr. | 181.59 Cr. | 156.44 Cr. |
Short Term Investments | 0 | 33 k | 33 k | 33 k |
Net Receivables | 100.56 Cr. | 78.37 Cr. | 103.25 Cr. | 73.67 Cr. |
Long Term Debt | 23.88 Cr. | 21.36 Cr. | 11.76 Cr. | 9.20 Cr. |
Inventory | 60.80 Cr. | 58.49 Cr. | 54.60 Cr. | 53.63 Cr. |
Accounts Payable | 31.87 Cr. | 30.79 Cr. | 29.68 Cr. | 35.04 Cr. |